My Competitor is Reviving an Old Patent Application. Is My Business at Risk?

Dear Atty. Gab,

Musta Atty! I am writing to you today with a heavy heart and a great deal of confusion. I run a small, local pharmaceutical company here in Cebu called “Salba Vida Pharma.” About five years ago, my research and development team identified a crucial compound for a hypertension drug whose patent had seemingly never been pursued in the Philippines. We did our due diligence, checking the Intellectual Property Office (IPO) records, and found an application from a big foreign company that was filed way back in the late 1980s but was marked as “abandoned.”

Believing the invention was in the public domain, we invested over ₱25,000,000 in research, clinical trials, and manufacturing to develop our own affordable version, which we call “Presyon-Control.” We successfully registered it with the FDA and have been supplying it to local communities for the past two years, significantly lowering the cost for many Filipino patients.

Just last week, we received a cease-and-desist letter from a major law firm representing that same foreign corporation. They claim they are in the process of reviving their decades-old patent application, blaming their previous lawyer’s negligence for the abandonment. They are threatening to sue us for infringement if their patent is granted. Can they really do this? Can an application that was abandoned more than 30 years ago be brought back to life? My entire business and the access to affordable medicine we provide are now at risk. I feel like the rug has been pulled out from under me. Any guidance would be deeply appreciated.

Respectfully yours,

Ricardo Cruz

Dear Ricardo,

Thank you for reaching out. I understand the immense stress and uncertainty you are facing. Your situation highlights a critical aspect of intellectual property law: the importance of strict procedural rules and the balance between an inventor’s rights and the public’s interest. It is a daunting position to be in, especially after investing significant resources based on information that appeared to be settled.

In essence, Philippine patent law provides a very strict, non-extendible window for an applicant to revive an abandoned patent application. The law is designed this way to create certainty. After a certain period, an invention that is not diligently protected is generally considered to have been forfeited, allowing the public, including competitors like yourself who act in good faith, to use and build upon it. The negligence of a former lawyer, especially when coupled with a client’s own prolonged inaction, is typically not a sufficient reason to bend these inflexible rules, particularly when third-party rights and public welfare have already intervened.

The Unforgiving Clock: Deadlines and Diligence in Patent Prosecution

The patent system is a carefully crafted bargain between an inventor and the public. In exchange for disclosing the invention, the government grants the inventor a temporary monopoly. However, this grant is not automatic; it is a privilege that must be pursued with diligence. The rules governing patent applications are strict to ensure fairness and prevent an applicant from indefinitely keeping an invention in limbo, thereby creating uncertainty in the marketplace. When an applicant fails to take required actions, the law provides a clear consequence: abandonment.

An application is considered abandoned if the applicant fails to respond to an official notice from the Intellectual Property Office (IPO) within a prescribed period. Once abandoned, the clock starts ticking on a final, limited chance for revival. The former patent rules, which would likely govern an application from the 1980s, were explicit about this timeframe.

Rule 113. Revival of abandoned application. — An application abandoned for failure to prosecute may be revived as a pending application if it is shown to the satisfaction of the Director that the delay was unavoidable. An abandoned application may be revived as a pending application within four months from the date of abandonment upon good cause shown… An application not revived within the specified period shall be deemed forfeited.

This four-month period is non-extendible. The rules do not provide exceptions that could stretch this period to several years, let alone decades. The term “deemed forfeited” is absolute. It means the applicant has lost their chance to pursue that specific application. Therefore, a petition for revival filed well beyond this window is, as a matter of law, filed out of time and should be denied.

Furthermore, the argument that a foreign company should be excused due to their local counsel’s negligence is a difficult one to sustain. The law generally holds that the negligence of a counsel binds the client. More importantly, the client has a corresponding duty to be proactive in monitoring the status of their own case. A prudent party is expected to maintain regular contact with their representative.

“No prudent party will leave the fate of his case entirely to his lawyer . . . . It is the duty of a party-litigant to be in contact with his counsel from time to time in order to be informed of the progress of his case.”

Allowing a patent application to lie dormant for years without any follow-up is not just the counsel’s fault; it demonstrates a lack of diligence on the part of the applicant as well. This shared inaction weakens any claim that the delay was “unavoidable” or “excusable.”

Finally, the patent system does not exist in a vacuum. It serves a larger societal purpose. When an invention enters the public domain, either by expiration or forfeiture of a patent, it becomes available for public use. This is essential for fostering innovation and, in the case of pharmaceuticals, promoting public health. The Supreme Court has affirmed the goals of our patent law, which include not only rewarding inventors but also ensuring that ideas eventually benefit everyone.

The patent law has a three-fold purpose: “first, patent law seeks to foster and reward invention; second, it promotes disclosures of inventions to stimulate further innovation and to permit the public to practice the invention once the patent expires; third, the stringent requirements for patent protection, seek to ensure that ideas in the public domain remain therefor the free use of the public.”

In your case, reviving a long-forfeited application would prejudice not only your business, which has established “intervening rights” by investing in good faith, but also the public interest by potentially removing an affordable hypertension medication from the market. Courts give significant weight to this factor, as a patent is a monopoly that should not be granted lightly, especially at the expense of public welfare.

Practical Advice for Your Situation

  • Verify the Abandonment Date: Immediately obtain certified true copies of the entire file wrapper (the complete record) of the foreign company’s patent application from the IPO. This will officially confirm the date the application was deemed abandoned and show that no revival was timely filed.
  • Document Your Good Faith: Compile all evidence of your company’s investment, including your initial patent search results, R&D expenses, FDA registration documents, and sales records. This establishes that you acted in good faith based on the application’s abandoned status.
  • Assert Your Intervening Rights: Your legal counsel should formally respond to the cease-and-desist letter. The response should firmly state that the application was forfeited decades ago, the revival period has long expired, and your company has established intervening rights by making substantial investments in the interim.
  • Challenge Any Revival Attempt: Should the foreign company manage to file a petition for revival, you have a strong legal interest to intervene in the proceedings at the IPO or on appeal. Your intervention would be crucial to show the prejudice your company and the public would suffer.
  • Highlight the Public Interest Angle: Emphasize that your product, “Presyon-Control,” provides an affordable alternative for a life-saving drug. The potential revival of the patent would create a monopoly, raising prices and harming Filipino patients who rely on your medication.
  • Do Not Halt Operations Based on a Threat: A cease-and-desist letter is not a court order. Based on the facts you’ve provided, their legal position appears very weak. Continue your lawful business operations unless a court directs you otherwise.

Your journey in providing an affordable alternative is commendable and aligns with the public interest goals of our laws. While the threat of litigation is serious, the foundational principles of patent law concerning deadlines, diligence, and forfeiture are strongly in your favor. Be firm, be prepared, and let the facts and the law speak for themselves.

Hope this helps!

Sincerely,
Atty. Gabriel Ablola

For more specific legal assistance related to your situation, please contact me through gaboogle.com or via email at connect@gaboogle.com.

Disclaimer: This correspondence is provided for informational purposes only and does not constitute legal advice. For specific legal guidance tailored to your situation, please schedule a formal consultation.

About the Author

Atty. Gabriel Ablola is a member of the Philippine Bar. Gaboogle is his personal blog where he shares legal analysis and commentary on Philippine law, covering areas such as Maritime Law, Corporate Law, Taxation Law, and Constitutional Law.

For professional legal services and inquiries, Atty. Ablola may be reached through ASG Law Partners at www.asglawpartners.com or gca@asglawpartners.com.

Other Posts

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *